XBI State Street SPDR S&P Biotech ETF
Company Analysis
Latest News
🟢 XBI is trading 4% up today after positive Moderna-Merck melanoma-vaccine results
XBI is trading 3.99% up now at $167.26 after positive Phase 3 melanoma-vaccine results from Moderna and Merck. - Personalized mRNA treatment met its primary...
Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
The biotech sector, proxied by the XBI ETF, is trading significantly higher today following a major positive catalyst from industry leader Moderna. The company...
Biotech Sector Surges on Landmark Cancer Therapy Trial Success from Merck and Moderna
The biotechnology sector, as measured by the XBI ETF, is trading sharply higher in the pre-market session, driven by positive, high-profile clinical trial...
Biotech Sector Rallies on Argenx-Forte M&A Deal
The biotech sector is trading higher, with the XBI ETF up over 2%, driven by news of a significant acquisition. Argenx announced a tender offer to purchase...
🟢 XBI is trading 3.1% up today on biotech earnings strength and broader risk-on rally
XBI is trading 3.1% up today at $151.83, benefiting from a strong biotech sector rally and broader risk-on sentiment across U.S. equities. • Biotech names are...
Biotech Sector Rallies on Strong Earnings and Positive Market Sentiment
The biotechnology sector, as measured by the XBI ETF, is trading higher today, influenced by a combination of positive company-specific news and a broader...
🔴 XBI is trading 3.5% down today amid a sector-wide risk-off shift
XBI is trading 3.5% down at $146.14 amid a sharp biotech pullback and a sector-wide risk-off shift. • The biotechnology group is down over 3% without a single...
Biotech Sector Declines Without A Clear Catalyst
The biotechnology sector, as measured by the XBI ETF, is down over 3% in the current trading session without a clear, identifiable catalyst. While there was...
Biotech Sector Surges on Strong Earnings and Major M&A Deal
The biotechnology sector, as measured by the XBI ETF, rallied over 2% due to a combination of strong corporate earnings and significant merger and acquisition...
Biotech Stocks Decline on Broad Market Weakness
The biotechnology sector, as measured by the XBI ETF, traded lower on Tuesday, moving in sympathy with a broader risk-off sentiment in the market. There is no...
Biotech Sector Rallies on Blockbuster M&A Deal and Positive Trial Data
The biotechnology sector is experiencing a significant upward trend, with the XBI ETF climbing over 2%. Today's rally is largely fueled by the announcement...
Biotech Sector Rallies on Strong Novartis Earnings and Continued M&A Optimism
The biotech sector, represented by the XBI ETF, is trading higher today, driven by better-than-expected second-quarter earnings from industry giant Novartis....
Biotech Sector Declines Amid Broader Market Weakness and Company-Specific News
The biotechnology sector, as measured by the XBI ETF, experienced a downturn of -2.04% in the current session. This move appears to be driven by a combination...
Biotech Sector Surges on Continued M&A Momentum
The biotech sector, proxied by the XBI ETF, is trading higher today, continuing a period of strong performance driven by a robust environment for mergers and...
🔴 XBI is trading 3% down today amid a broader risk-off pullback in biotech and tech
XBI is trading 3% down at $151.50 as biotech stocks slide alongside a sharper tech and AI-led sell-off. • Investors are trimming exposure to higher-risk...
Biotech Stocks Decline Amid Broader Market Tech Sell-Off
The biotech sector, as measured by the XBI ETF, fell 2.00% in the current session, mirroring a wider market downturn led by a sell-off in technology and...
🔴 XBI is trading 3.32% down today on broader biotech sector pressure and profit-taking
XBI is trading 3.32% down at $158.82 amid broader biotech sector pressure and a shift toward softer risk sentiment. • The decline follows a weak open for...
🟢 XBI is trading 3.1% up today amid sector momentum, spurred by major M&A activity in the biotech sector, and a rising borrow rate
• XBI is trading 3.1% up at $154.35 following strong momentum in the biotechnology sector. • This rally is notably bolstered by Merck KGaA's $11.3 billion cash...
🟢 XBI is trading 3.01% up today as multi-day biotech rally extends
XBI is trading at +3.01% now at $151.46 after extending a multi-day biotech rally. • The move is driven by broader biotechnology sector momentum and a...
🟢 XBI is trading 3.7% up today as biotech rally extends
XBI is trading 3.7% up at $145.76 in pre-market, extending a strong multi-day rally in biotech names. • The move appears driven by continued sector momentum...